gemfibrozil has been researched along with imatinib mesylate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Backman, JT; Filppula, AM; Neuvonen, PJ; Niemi, M; Tornio, A | 1 |
1 trial(s) available for gemfibrozil and imatinib mesylate
Article | Year |
---|---|
Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metabolite.
Topics: Absorption; Adult; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Benzamides; Cross-Over Studies; Cytochrome P-450 CYP2C8; Drug Antagonism; Female; Gemfibrozil; Genotype; Humans; Hypolipidemic Agents; Imatinib Mesylate; Male; Piperazines; Pyrimidines; Young Adult | 2013 |
1 other study(ies) available for gemfibrozil and imatinib mesylate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |